Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation

PURPOSE: Both epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy are widely applied for the treatment of advanced non-small-cell lung cancer (NSCLC) with EGFR mutations, and the combination of EGFR-TKIs and chemotherapy has been used for advanced NSCLC patients;...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biologics
Glavni autori: Wen, Miaomiao, Xia, Jinghua, Sun, Ying, Wang, Xuejiao, Fu, Xianghui, Zhang, Yanning, Zhang, Zhipei, Zhou, Yongan, Li, Xiaofei
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2018
Teme:
Perspectives
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6280904/
https://ncbi.nlm.nih.gov/pubmed/30555222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S169305
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items